Q3 2017 Holdings
Filed 2017-11-03 | 11 holdings | $176.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | Common Stock | 699374302 | $65.3K | 2,600,410 | 36.9% |
| Juno Therapeutics | Common Stock | 48205A109 | $48.2K | 1,074,612 | 27.3% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $16.9K | 314,348 | 9.6% |
| Sienna Biopharmaceuticals(SNNAQ) | Common Stock | 82622H108 | $16.9K | 758,610 | 9.5% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $9.0K | 579,650 | 5.1% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $6.9K | 1,204,053 | 3.9% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $4.4K | 551,477 | 2.5% |
| Egalet | Common Stock | 28226B104 | $3.7K | 2,889,926 | 2.1% |
| Cidara Therapeutics | Common Stock | 171757107 | $3.6K | 444,965 | 2.0% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $1.3K | 223,457 | 0.7% |
| Essa Pharma | Common Stock | 29668H104 | $492 | 1,696,969 | 0.3% |